Specific tumoricidal activity of cytotoxic macrophages and cytotoxic lymphocytes

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00199122PMID 3487380PMCID PMC11038568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Somatosensory Stimulation With XNKQ Acupuncture Modulates Functional Connectivity of Motor Areas

  2019cited by this paper
• Macrophages and antitumor reactions

  2004cited by this paper
• Lymphocyte-induced macrophage cytotoxicity. III. Induction of specific macrophage cytotoxicity is independent of lipopolysaccharide.

  1986cited by this paper
• Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

  1985cited by this paper
• Macrophage T lymphocyte interactions in the anti-tumor immune response: a mathematical model.

  1985cited by this paper
• Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor

  1984cited by this paper
• The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood.

  1984cited by this paper
• Lymphocyte induced macrophage cytotoxicity: characterization of the macrophage cytotoxicity-inducing lymphocyte.

  1984influential reference
• Lymphocyte-induced macrophage cytotoxicity. Production of specific macrophage arming factor by sensitized Lyt 1+2+ T-lymphocytes.

  1984cited by this paper
• Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.

  1984cited by this paper
• Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon.

  1983cited by this paper
• Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells

  1983cited by this paper
• High‐grade tumor‐specific immunity induced by L1210 leukemia variants obtained from the culture of L1210 cells fused with Lesch‐Nyhan fibroblasts

  1983cited by this paper
• Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody.

  1983cited by this paper
• Role of Corynebacterium parvum in the activation of peritoneal macrophages. II. Identification of distinguishable anti-tumor activities by macrophage subpopulations.

  1983cited by this paper
• Macrophage-activating factors from different T cell clones induce distinct macrophage functions.

  1983cited by this paper
• Macrophage activating factor is not identical with immune interferon or a factor inducing differentiation of mouse myeloid leukemic cells.

  1982cited by this paper
• Host macrophages are involved in systemic adoptive immunity against tumors

  1982cited by this paper
• The induction of lymphocytes with the capacity to render macrophages cytotoxic in an allogeneic murine system.

  1982influential reference
• Tumor-cytotoxic activity of resident rat macrophages.

  1981cited by this paper
• Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

  1981cited by this paper
• Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors

  1981cited by this paper
• Adoptive immunity to the guinea pig line 10 hepatoma and the nature of in vitro lymphoid-tumor cell interactions.

  1981cited by this paper
• Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes

  1980cited by this paper
• Interaction of Bacillus Calmette--Guérin-activated macrophages and neoplastic cells in vitro. I. Conditions of binding and its selectivity.

  1980cited by this paper
• Cytolytic activity against tumor cells by macrophage cell lines and augmentation by macrophage stimulants

  1980cited by this paper
• Interaction of Bacillus Calmette--Guérin-activated macrophages and neoplastic cells in vitro II. The relationship of selective binding to cytolysis.

  1980cited by this paper
• Stimulation of guinea pig macrophage pinocytosis by lipopolysaccharides (LPS): evidence that LPS acts directly on the macrophage.

  1980cited by this paper
• Lysozyme, glucan-activated macrophages and neoplasia.

  1979cited by this paper
• Natural cytotoxic macrophages in the peritoneal cavity of mice.

  1979cited by this paper
• A functional comparison of tumor cell killing by activated macrophages and natural killer cells

  1979cited by this paper
• Lysozyme, glucan-activated macrophages and neoplasia.

  1979cited by this paper
• Lack of correlation between in vivo rejection of syngeneic fibrosarcomas and in vitro non-specific macrophage cytotoxicity.

  1978cited by this paper
• Arming of macrophages with lymphocytes from mice immunized with tumor tissue.

  1977cited by this paper
• The biologic activity of MER-BCG in experimental systems and preliminary clinical studies.

  1977cited by this paper
• THE MACROPHAGE AS A TUMORICIDAL EFFECTOR CELL: A REVIEW OF IN VIVO AND IN VITRO STUDIES ON THE MECHANISM OF THE ACTIVATED MACROPHAGE NONSPECIFIC CYTOTOXIC REACTION *

  1976cited by this paper
• Tumor‐bound immunoglobulins. I. Further analysis of the characteristics of binding of immunoglobulins to In vivo‐grown tumor cells

  1976cited by this paper
• Promotion of tumor growth in vivo by antimacrophage agents.

  1976cited by this paper
• Therapy with allogeneic immune peritoneal cells.

  1974cited by this paper
• Eradication of tumour cells by successive injections of allogeneic immune and hyperimmune peritoneal cells in a murine lymphoma system.

  1974cited by this paper
• The Role of a Cytophilic Factor from ChallengedImmune Peritoneal Lymphocytesin Specific Macrophage 1

  1974cited by this paper
• The role of a cytophilic factor from challenged immune peritoneal lymphocytes in specific macrophage cytotoxicity.

  1974cited by this paper
• A rapid method for the isolation of functional thymus‐derived murine lymphocytes

  1973cited by this paper
• Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.

  1972influential reference

• Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cells

  2005cites this paper
• Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejection

  2005cites this paper
• Cyclophosphamide modifies the induction kinetics but not cell types and cytotoxic mechanisms of antitumor cells elicited with OK-432 plus attenuated tumor cells

  2005cites this paper
• The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice

  2004cites this paper
• Factors influencing antibody-mediated cytotoxicity during the immunotherapy of Rauscher-virus-induced myeloid leukemic cells

  2004cites this paper
• Effect of local interleukin-2 treatment on spontaneous tumours of different immunogenic strength

  1999cites this paper
• Interleukin-2: hope in cases of cisplatin-resistant tumours

  1998cites this paper
• Involvement of the omental lymphoid organ in the induction of peritoneal immunity against tumor cells.

  1993cites this paper
• Isolation of a novel tumor protein that induces resistance to natural killer cell lysis.

  1990cites this paper
• Factors affecting serum sialic acid levels.

  1989cites this paper
• Heterogeneous transplantability of mouse sarcoma cells due to differences in sensitivity to lysis by macrophages

  1988cites this paper
• Essential requirement of I-A region-identical host bone marrow or bone marrow-derived cells for tumor neutralization by primed L3T4+ T cells.

  1987cites this paper
• Use of monosaccharide inhibitors to study the cytostatic action of cytotoxic T lymphocytes, macrophages, and nonadherent splenocytes

  1987cites this paper